A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype

Annals of the Rheumatic Diseases

Volumn 68, Issue 10, 2009, Pages 1618-1620

  Rueda, B ^a   Simeon, C ^b   Hesselstrand, R ^c   Herrick, A ^d   Worthington, J ^d   Ortego Centeno, N ^e   Riemekasten, G ^f   Fonollosa, V ^b   Vonk, M C ^g   Van Den Hoogen, F H J ^h   Sanchez Roman J ⁱ   Aguirre Zamorano, M A ^j   Garcia Portales R ^k   Pros, A ^l   Camps, M T ^m   Gonzalez Gay, M A ⁿ   Gonzalez Escribano, M F ⁱ   Coenen, M J ^g   Lambert, N ^o   Nelson, J L ^p   Radstake, T R D J ^g   Martin, J ^a   more..

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b Servicio de Medinina Interna   (Spain)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h Sint Maartenskliniek ^*  (Netherlands)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^j HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^k HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^l HOSPITAL DEL MAR   (Spain)

^m HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

ⁿ HOSPITAL XERAL CALDE   (Spain)

^o INSERM   (France)

^p UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE ANTIBODY; CONNECTIVE TISSUE GROWTH FACTOR; SCL 70 ANTIBODY;

ALLELE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; ETHNICITY; FRANCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; NORTH AMERICA; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REPLICATION STUDY; SPAIN; SWEDEN; SYSTEMIC SCLEROSIS; UNITED KINGDOM;

CASE-CONTROL STUDIES; CONNECTIVE TISSUE GROWTH FACTOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SCLERODERMA, SYSTEMIC;

EID: 70349386180     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.100180     Document Type: Article

References (13)

1. Agarwal SK, Tan FK, Arnett FC. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am 2008;34:17-40. (Pubitemid 351337628)
2. Fonseca C, Lindahl GE, Ponticos M, et al. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med 2007;357:1210-1220 (Pubitemid 47443180)
3. Gourh P, Mayes MD, Arnett FC. CTGF polymorphism associated with systemic sclerosis. N Engl J Med 2008;358:308-9; author reply 309.
4. Anonymous. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-590
5. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-1576 (Pubitemid 32660630)
6. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205 (Pubitemid 18073738)
7. Matucci-Cerinic M, D'Angelo S, Denton CP, et al. Assessment of lung involvement. Clin Exp Rheumatol 2003;21:S19-23.
8. Cordell HJ, Clayton DG. Genetic association studies. Lancet 2005;366:1121-1131
9. Lohmueller KE, Pearce CL, Pike M, et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-182 (Pubitemid 36177070)
10. Van Beek JP, Kennedy L, Rockel JS, et al. The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res Ther 2006;8:R36.
11. Pannu J, Gore-Hyer E, Yamanaka M, et al. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma. Arthritis Rheum 2004;50:1566-1577 (Pubitemid 38608079)
12. Shi-Wen X, Renzoni EA, Kennedy L, et al. Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts. Matrix Biol 2007;26:625-632 (Pubitemid 350186096)
13. Dziadzio M, Usinger W, Leask A, et al. N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma. QJM 2005;98:485-492 (Pubitemid 41418671)